Concepedia

Eleanor Clancy‐Thompson

EC

Statistics

Publications

13

Citations

661

H-Index

11

Active since

2010

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

University of Virginia

Dartmouth College

Eleanor Clancy‐Thompson is an author at Dana-Farber Cancer Institute specializing in immunology, oncology, and cancer immunology.

Publications per year

2010–2024

13

Publications

13

Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

Susannah L. Hewitt, D. R. Shackleton Bailey, John Zielinski et al. · Clinical Cancer Research · 2020 · 218 citations · Full text

, , +17

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Bérengère Salomé, John P. Sfakianos, Daniel Ranti et al. · Cancer Cell · 2022 · 127 citations · Full text

, , +13

Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma

Lynn T. Dengel, Allison G. Norrod, Briana L. Gregory et al. · Journal of Immunotherapy · 2010 · 65 citations · Full text

, , +17

Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease

Eleanor Clancy‐Thompson, Thomas J. Perekslis, Walburga Croteau et al. · Cancer Immunology Research · 2015 · 42 citations · Full text

, , +17

Monoclonal Invariant NKT (iNKT) Cell Mice Reveal a Role for Both Tissue of Origin and the TCR in Development of iNKT Functional Subsets

Eleanor Clancy‐Thompson, Gui Zhen Chen, Paul Tyler et al. · The Journal of Immunology · 2017 · 34 citations · Full text

, , +14

1–5 of 13